As recently reported in The Wall Street Journal, The New York Times, and Bloomberg News, there is a controversy brewing over robotic surgery and whether it is superior to alternative... Read more »
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars